Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Dapagrip-M Tablet ER

Prescription Icon
Prescription Required

Marketer

Nunchi Pharma Pvt. Ltd.

Salt Composition

Dapagliflozin (10mg) + Metformin (500mg)

Overview Dapagrip-M Tablet ER

Dapagrip-M Extended-Release tablets combine two medications to manage type 2 diabetes. This treatment helps regulate elevated blood glucose, lessening the likelihood of severe diabetic complications and contributing to heart disease prevention. Dapagrip-M ER can be taken with food, consistently at the same time each day for optimal adherence. Dosage is determined by your physician; discontinuation requires their consultation to avoid potential blood sugar spikes and consequent risks like kidney impairment or vision loss. This medication forms part of a comprehensive diabetes management plan, including diet, exercise, and weight control as directed by your doctor. Common side effects include throat irritation, nasal stuffiness, rhinorrhea, headache, nausea, emesis, and diarrhea. Adequate hydration minimizes dehydration risk. Genital fungal infections may occur; diligent hygiene helps mitigate this. Prior to commencing treatment, disclose kidney or liver issues, urinary tract infections, or diuretic use to your physician. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption to reduce the potential for heightened side effects. Regular blood glucose monitoring is essential during treatment.

Primary Ingredients of Dapagrip-M Tablet ER

No information provided. Unable to rephrase.

Uses of Dapagrip-M Tablet ER

Managing type 2 diabetes

Major Benefits of Dapagrip-M Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapagrip-M Extended-Release Tablets should be administered with a meal.

Common Side effects of Dapagrip-M Tablet ER:

  • Nausea
  • Vomiting
  • Diarrhea
  • Genital fungal infection
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Urinary tract infection
  • Polyuria
  • Flatulence
  • Skin rash
  • Taste change
  • Difficulty in urination
  • Hypoglycemia (low blood glucose level)
  • Tremors
  • Dizziness
  • Back pain
  • Increased hematocrit
  • Decreased creatinine clearance
  • Dyslipidemia

How to use Dapagrip-M Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapagrip-M Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.

How Dapagrip-M Tablet ER works:

Dapagliflozin and Metformin, combined in Dapagrip-M Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual-action approach leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Dapagrip-M Tablet ER and alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Dapagrip-M tablets may pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Dapagrip-M tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Extended-release Dapagrip-M tablets require careful administration in individuals with impaired kidney function. Dosage modification for Dapagrip-M extended-release tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using extended-release Dapagrip-M tablets. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Dapagrip-M Tablet ER :

Should you forget a Dapagrip-M Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Dapagrip-M Tablet ER

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management
Dapagrip-M Tablet ER
94
MRP 109
13% off